Literature DB >> 11889165

Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease.

Stig Andersen1, Klaus Michael Pedersen, Niels Henrik Bruun, Peter Laurberg.   

Abstract

High individuality causes laboratory reference ranges to be insensitive to changes in test results that are significant for the individual. We undertook a longitudinal study of variation in thyroid function tests in 16 healthy men with monthly sampling for 12 months using standard procedures. We measured serum T(4), T(3), free T(4) index, and TSH. All individuals had different variations of thyroid function tests (P < 0.001 for all variables) around individual mean values (set points) (P < 0.001 for all variables). The width of the individual 95% confidence intervals were approximately half that of the group for all variables. Accordingly, the index of individuality was low: T(4) = 0.58; T(3) = 0.54; free T(4) index = 0.59; TSH = 0.49. One test result described the individual set point with a precision of +/- 25% for T(4), T(3), free T(4) index, and +/- 50% for TSH. The differences required to be 95% confident of significant changes in repeated testing were (average, range): T(4) = 28, 11-62 nmol/liter; T(3) = 0.55, 0.3--0.9 nmol/liter; free T4 index = 33, 15-61 nmol/liter; TSH = 0.75, 0.2-1.6 mU/liter. Our data indicate that each individual had a unique thyroid function. The individual reference ranges for test results were narrow, compared with group reference ranges used to develop laboratory reference ranges. Accordingly, a test result within laboratory reference limits is not necessarily normal for an individual. Because serum TSH responds with logarithmically amplified variation to minor changes in serum T(4) and T(3), abnormal serum TSH may indicate that serum T(4) and T(3) are not normal for an individual. A condition with abnormal serum TSH but with serum T(4) and T(3) within laboratory reference ranges is labeled subclinical thyroid disease. Our data indicate that the distinction between subclinical and overt thyroid disease (abnormal serum TSH and abnormal T(4) and/or T(3)) is somewhat arbitrary. For the same degree of thyroid function abnormality, the diagnosis depends to a considerable extent on the position of the patient's normal set point for T(4) and T(3) within the laboratory reference range.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11889165     DOI: 10.1210/jcem.87.3.8165

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  157 in total

Review 1.  Transplacental thyroxine and fetal brain development.

Authors:  R Thomas Zoeller
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassays.

Authors:  O P Soldin; L Hilakivi-Clarke; E Weiderpass; S J Soldin
Journal:  Clin Chim Acta       Date:  2004-11       Impact factor: 3.786

3.  The metabolic consequences of thyroxine replacement in adult hypopituitary patients.

Authors:  Helena Filipsson Nyström; Ulla Feldt-Rasmussen; Ione Kourides; Vera Popovic; Maria Koltowska-Häggström; Björn Jonsson; Gudmundur Johannsson
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

4.  Genetics of thyroid function and disease.

Authors:  Vijay Panicker
Journal:  Clin Biochem Rev       Date:  2011-11

5.  Specific treatment of residual fatigue in depressed patients.

Authors:  Humberto Marin; Matthew A Menza
Journal:  Psychiatry (Edgmont)       Date:  2004-09

6.  The -258A/G (SNP rs12885300) polymorphism of the human type 2 deiodinase gene is associated with a shift in the pattern of secretion of thyroid hormones following a TRH-induced acute rise in TSH.

Authors:  Maya Y Peltsverger; Peter W Butler; Anna Teresa Alberobello; Sheila Smith; Yanina Guevara; Ornella M Dubaz; Javier A Luzon; Joyce Linderman; Francesco S Celi
Journal:  Eur J Endocrinol       Date:  2012-02-03       Impact factor: 6.664

7.  Polybrominated diphenyl ethers, hydroxylated polybrominated diphenyl ethers, and measures of thyroid function in second trimester pregnant women in California.

Authors:  Ami R Zota; June-Soo Park; Yunzhu Wang; Myrto Petreas; R Thomas Zoeller; Tracey J Woodruff
Journal:  Environ Sci Technol       Date:  2011-08-19       Impact factor: 9.028

Review 8.  Anterior pituitary hormone replacement therapy--a clinical review.

Authors:  Christoph J Auernhammer; George Vlotides
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

9.  Assessment of thyroid function: towards an integrated laboratory--clinical approach.

Authors:  Jim Stockigt
Journal:  Clin Biochem Rev       Date:  2003-11

Review 10.  Subclinical hyperthyroidism: to treat or not to treat?

Authors:  E H Hoogendoorn; M den Heijer; A P J van Dijk; A R Hermus
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.